U.S. markets closed

Emerald Health Therapeutics, Inc. (EMH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3150-0.0200 (-5.97%)
At close: 3:57PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3350
Open0.3400
Bid0.3100 x 0
Ask0.3150 x 0
Day's Range0.3150 - 0.3400
52 Week Range0.1200 - 0.5300
Volume354,162
Avg. Volume756,416
Market Cap64.584M
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-0.6960
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Emerald Health Therapeutics to Close Greater Vancouver Production Facility
      Newsfile

      Emerald Health Therapeutics to Close Greater Vancouver Production Facility

      Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will cease operations at its cannabis production facility in Greater Vancouver, British Columbia effective March 31, 2021 and will consider strategic alternatives for this facility. "Closing our Greater Vancouver production facility is part of Emerald's revised business strategy and transition away from the value segment of the cannabis market toward science-driven product ...

    • Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans
      Newsfile

      Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans

      Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received from Village Farms International Inc. $19.9M plus $621,534.25 in interest, representing full repayment of the promissory note issued by Village Farms to Emerald as part of its purchase of Emerald's interest in the Pure Sunfarms joint venture which closed in November 2020. This was the final payment due as part of this transaction. "After ...

    • Emerald Health Therapeutics Promotes Two Executives to Senior Roles
      Newsfile

      Emerald Health Therapeutics Promotes Two Executives to Senior Roles

      Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has promoted Orville Bovenschen to the position of Senior Vice President, Operations and Rebecca Wong to Senior Vice President, Quality & Regulatory Affairs.Mr. Bovenschen has over 16 years of progressive experience in financial management, project and operations management, and strategy development and operational planning, including risk management. With Emerald since 2017, he has overseen ...